CN1129432C - 采用二硫醚降低碳铂的毒性作用 - Google Patents

采用二硫醚降低碳铂的毒性作用 Download PDF

Info

Publication number
CN1129432C
CN1129432C CN97198132A CN97198132A CN1129432C CN 1129432 C CN1129432 C CN 1129432C CN 97198132 A CN97198132 A CN 97198132A CN 97198132 A CN97198132 A CN 97198132A CN 1129432 C CN1129432 C CN 1129432C
Authority
CN
China
Prior art keywords
carboplatin
disulfide
purposes
general formula
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN97198132A
Other languages
English (en)
Chinese (zh)
Other versions
CN1230887A (zh
Inventor
F·H·豪希尔
K·哈里达斯
D·G·莱迪
P·希萨拉姆鲁
D·姆拉里
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BioNumerik Pharmaceuticals Inc
Original Assignee
BioNumerik Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioNumerik Pharmaceuticals Inc filed Critical BioNumerik Pharmaceuticals Inc
Publication of CN1230887A publication Critical patent/CN1230887A/zh
Application granted granted Critical
Publication of CN1129432C publication Critical patent/CN1129432C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN97198132A 1996-09-23 1997-09-23 采用二硫醚降低碳铂的毒性作用 Expired - Fee Related CN1129432C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2643096P 1996-09-23 1996-09-23
US60/026,430 1996-09-23

Publications (2)

Publication Number Publication Date
CN1230887A CN1230887A (zh) 1999-10-06
CN1129432C true CN1129432C (zh) 2003-12-03

Family

ID=21831779

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97198132A Expired - Fee Related CN1129432C (zh) 1996-09-23 1997-09-23 采用二硫醚降低碳铂的毒性作用

Country Status (11)

Country Link
EP (1) EP0957920B1 (ja)
JP (3) JP2001500872A (ja)
CN (1) CN1129432C (ja)
AT (1) ATE210987T1 (ja)
AU (1) AU712548B2 (ja)
CA (1) CA2263166C (ja)
DE (1) DE69709404T2 (ja)
DK (1) DK0957920T3 (ja)
ES (1) ES2170414T3 (ja)
PT (1) PT957920E (ja)
WO (1) WO1998011898A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177411B1 (en) * 1999-02-09 2001-01-23 Bionumerik Pharmaceuticals, Inc. Method for treating heavy metal poisoning
BR0110403A (pt) 2000-04-26 2004-02-25 Univ Oregon Health Sciences Administração de um composto quimioprotetor baseado em tiol
EP1351677A4 (en) * 2001-01-19 2009-08-19 Bionumerik Pharmaceuticals Inc CANCER TREATMENT METHOD
US8710095B2 (en) 2002-04-30 2014-04-29 Bionumerik Pharmaceuticals, Inc. Drugs for prophylaxis or mitigation of taxane-induced neurotoxicity
US7282602B2 (en) * 2004-09-21 2007-10-16 Bionumerik Pharmaceuticals, Inc. Medicinal disulfide salts
WO2009113983A1 (en) * 2008-03-14 2009-09-17 Bionumerik Pharmaceuticals, Inc. Treatment methods and compositions for lung cancer, adenocarcinoma, and other medical conditions
CN111632146B (zh) * 2020-05-29 2021-09-28 中山大学 Oat抑制剂和溶瘤病毒在制备抗肿瘤药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789000A (en) * 1994-11-14 1998-08-04 Bionumerik Pharmaceuticals, Inc. Sterile aqueous parenteral formulations of cis-diammine dichloro platinum

Also Published As

Publication number Publication date
EP0957920A1 (en) 1999-11-24
DE69709404T2 (de) 2002-05-29
EP0957920B1 (en) 2001-12-19
ES2170414T3 (es) 2002-08-01
JP2009143950A (ja) 2009-07-02
DK0957920T3 (da) 2002-04-02
CA2263166A1 (en) 1998-03-26
AU4313397A (en) 1998-04-14
CN1230887A (zh) 1999-10-06
PT957920E (pt) 2002-06-28
AU712548B2 (en) 1999-11-11
JP2001500872A (ja) 2001-01-23
ATE210987T1 (de) 2002-01-15
WO1998011898A1 (en) 1998-03-26
DE69709404D1 (de) 2002-01-31
CA2263166C (en) 2006-12-12
JP2013155200A (ja) 2013-08-15

Similar Documents

Publication Publication Date Title
JP4171526B2 (ja) 2,2′−ジチオ−ビス(エタンスルホネート)(ジメスナ)と組み合わせたシスプラチン組成物
EP2458996B1 (en) Novel oral forms of a phosphonic acid derivative
US8552048B2 (en) Phosphoramidate alkylator prodrugs for the treatment of cancer
EA008090B1 (ru) Фармацевтические композиции соединения платины
JP2009091361A (ja) 10−プロパルギル−10−デアザアミノプテリンの精製組成物と腫瘍の治療への同化合物の使用方法
JP2013155200A (ja) ジチオエーテルを用いたカルボプラチンの毒減少効果
US8450356B2 (en) Pharmaceutical composition
KR20020095022A (ko) 이중 디카르복실산 디아미노플라틴 착체의 항종양 유도체, 그의 제조방법, 그것을 함유하는 약학조성물 및 그 유도체의 적용
WO1998002163A9 (en) Purified compositions of 10-propargyl-10-deazaaminopterin and methods of using same in the treatment of tumors
JP2009143950A6 (ja) ジチオエーテルを用いたカルボプラチンの毒減少効果
WO2001076569A2 (en) An improved pt(iv) antitumor agent
CN101076513A (zh) 药用二硫化物盐
US6596889B1 (en) Nitrates of bis-platinum complexes with polyamine ligands
US6172119B1 (en) Method of treating acute renal failure
US6197831B1 (en) Method of treating septic shock
KR930004647B1 (ko) 신장 질환 치료제
US4758589A (en) Tetraphosphine-coordinated gold(I) complexes
MXPA99002692A (en) Reducing toxic effects of carboplatin using dithioethers
US4675427A (en) Tetraphosphine-coordinated gold(I) complexes
EP0202854A2 (en) Phosphine gold compounds

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20031203

Termination date: 20160923

CF01 Termination of patent right due to non-payment of annual fee